Correlation Between Maravai Lifesciences and Y MAbs

Can any of the company-specific risk be diversified away by investing in both Maravai Lifesciences and Y MAbs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maravai Lifesciences and Y MAbs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Maravai Lifesciences Holdings and Y mAbs Therapeutics, you can compare the effects of market volatilities on Maravai Lifesciences and Y MAbs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maravai Lifesciences with a short position of Y MAbs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maravai Lifesciences and Y MAbs.

Diversification Opportunities for Maravai Lifesciences and Y MAbs

0.61

Correlation Coefficient

Maravai Lifesciences  Y MAbs

Poor diversification

The 3 months correlation between Maravai and YMAB is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Maravai Lifesciences Holdings and Y mAbs Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Y mAbs Therapeutics and Maravai Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maravai Lifesciences Holdings are associated (or correlated) with Y MAbs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Y mAbs Therapeutics has no effect on the direction of Maravai Lifesciences i.e., Maravai Lifesciences and Y MAbs go up and down completely randomly.

Pair Corralation between Maravai Lifesciences and Y MAbs

Given the investment horizon of 90 days Maravai Lifesciences Holdings is expected to under-perform the Y MAbs. In addition to that, Maravai Lifesciences is 1.66 times more volatile than Y mAbs Therapeutics. It trades about -0.39 of its total potential returns per unit of risk. Y mAbs Therapeutics is currently generating about -0.22 per unit of volatility. If you would invest  580.00  in Y mAbs Therapeutics on December 4, 2024 and sell it today you would lose (95.00) from holding Y mAbs Therapeutics or give up 16.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Maravai Lifesciences Holdings  vs.  Y mAbs Therapeutics

Maravai Lifesciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Maravai Lifesciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Y mAbs Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Y mAbs Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Maravai Lifesciences and Y MAbs

The main advantage of trading using opposite Maravai Lifesciences and Y MAbs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maravai Lifesciences position performs unexpectedly, Y MAbs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Y MAbs will offset losses from the drop in Y MAbs' long position.

The idea behind Maravai Lifesciences Holdings and Y mAbs Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.